Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients’ specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order-driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing, and sales network
5. Diversified business operations
| Date | GMP | Kostak | Subject To Sauda | |
| 15 March 2023 | ₹7 | ₹- | ₹- | |
| 14 March 2023 | ₹10 | ₹- | ₹- | |
| 13 March 2023 | ₹10 | ₹- | ₹- | |
| 12 March 2023 | ₹10 | ₹- | ₹- | |
| 11 March 2023 | ₹10 | ₹- | ₹- | |
| 10 March 2023 | ₹10 | ₹- | ₹- |
Sudarshan Pharma Industries SME IPO Date & Price Band.
| IPO Open: | Mar 9, 2023 |
| IPO Close: | Mar 14, 2023 |
| IPO Size: | ₹50.10 Crores |
| Price Band: | ₹71 to ₹73 per share |
| Listing on: | BSE SME |
| Retail Portion: | Not less than 35% of the Net Issue |
| Equity: | 6,862,400 shares |
| Face Value: | ₹10 per share |
Sudarshan Pharma Industries SME IPO Market Lot
The Sudarshan Pharma Industries IPO lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹116,800).
Shares: Minimum 1600 share
Minimum Amount: ₹116,800
Maximum Amount: ₹116,800
Sudarshan Pharma Industries SME IPO Allotment & Listing:
- Basis of Allotment: Mar 17, 2023
- Refunds: Mar 20, 2023
- Credit to Demat accounts: Mar 21, 2023
- Listing: Mar 22, 2023